Today: 10 June 2026
Lam Research stock climbs as upbeat outlook keeps chip-tool rally in play
30 January 2026
1 min read

Lam Research stock climbs as upbeat outlook keeps chip-tool rally in play

New York, January 29, 2026, 18:08 EST — After-hours

Lam Research (LRCX.O) shares climbed 3.6% to $248.17 in after-hours trading Thursday, building on gains sparked by the chipmaking tools supplier’s upbeat outlook. During the regular session, the stock fluctuated between $236.85 and $254.50.

The guidance is crucial since Lam occupies the center of a spending cycle investors now see as a gauge for how aggressively chipmakers are investing in advanced memory and cutting-edge logic. The equipment sector has grown increasingly reactive to any indication that orders are expanding beyond just a handful of “AI winners.”

Lam sells etch and deposition systems that build chips on silicon wafers, the slices of silicon turned into semiconductors. When factory investment ramps up, Lam’s revenue—and its stock—can surge just as fast.

Late Wednesday, the company projected revenue for the March quarter at $5.7 billion, plus or minus $300 million, and adjusted earnings of $1.35 per share, with a 10-cent margin, both beating analysts’ estimates of $5.34 billion and $1.20, according to LSEG data. It also posted December-quarter revenue of $5.34 billion and adjusted earnings of $1.27 per share, surpassing forecasts of $5.26 billion and $1.17.

Lam’s ties to memory tech have kept it front and center for many traders, as high-bandwidth memory (HBM) — a stacked DRAM type used in AI accelerators — pushes for additional layers and finer manufacturing processes. More steps typically translate into a greater demand for tools.

Lam reported that China made up 35% of its revenue in the December quarter, with Taiwan and Korea each providing 20%. CEO Tim Archer highlighted that the company’s growing portfolio is “enabling the market’s transition to smaller, more complex three-dimensional devices and packages.” PR Newswire

During the earnings call, Archer told analysts he expects industry spending on wafer fab equipment—the pricey tools for chip production—to hit roughly $135 billion in 2026. He noted demand will probably be “second-half weighted.” CFO Doug Bettinger projected a March-quarter gross margin around 49%, plus or minus one percentage point. The Motley Fool

Other companies are echoing a similar story. KLA (KLAC.O), known for its process control tools that measure and inspect chips during production, beat quarterly expectations on Thursday. It projected March-quarter revenue near $3.35 billion, with a $150 million margin either way. CEO Rick Wallace pointed to AI-driven demand as a key growth factor behind investments in foundry, memory, and advanced packaging.

But the situation can shift quickly. A hiccup in customer factory expansions, new export limits related to China sales, or a wider tech sell-off could all drag down orders and squeeze margins—particularly if spending remains uneven and weighted toward the later part of the year.

Traders will eye chip-equipment forecasts alongside U.S. inflation data next session, with the December Producer Price Index landing Friday at 8:30 a.m. EST.

Applied Materials (AMAT.O) is set to report its fiscal first-quarter earnings on Feb. 12, with the call scheduled for 4:30 p.m. ET.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Amazon stock slips after report of a mega OpenAI check — what AMZN investors watch next
Previous Story

Amazon stock slips after report of a mega OpenAI check — what AMZN investors watch next

Accenture stock slides 3% as new share award pool wins approval — what investors watch next
Next Story

Accenture stock slides 3% as new share award pool wins approval — what investors watch next

Go toTop